Policy papers and consultations

We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.

• From: Department of Health and Social Care
• Updated: 25 April 2024

• Making amendments to the references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012

  Summary The aim of this consultation is to seek the views of stakeholders…

The government’s plan to support a thriving UK medtech sector and make sure the health and care system can reliably access safe, effective and innovative medical technologies to deliver the best outcomes for patients.

• From: Department of Health and Social Care
• Updated: 9 April 2024

• Medical technology strategy

  Foreword The role of medical technology in improving health outcomes…

Achievements made since the launch of the medtech strategy and the next steps to boost the adoption of medical technology in the NHS.

• From: Department of Health and Social Care
• Updated: 9 April 2024

• The medical technology strategy: one year on

  Ministerial foreword Time and time again innovative medical technology…

This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.

• From: Department of Health and Social Care
• Updated: 28 March 2024

This consultation seeks views on proposals to update the statutory scheme to control the cost of branded health service medicines.

• From: Department of Health and Social Care
• Updated: 18 March 2024

Government’s response to the independent review into racial, ethnic and other factors leading to unfair biases in the design and use of medical devices.

• From: Department of Health and Social Care
• Updated: 11 March 2024

We are seeking your views on the design, development, evaluation and use of medical devices.

• From: Department of Health and Social Care
• Updated: 11 March 2024

The government’s response to the Science, Innovation and Technology Committee’s report into the antimicrobial potential of bacteriophages.

• From: Department of Health and Social Care
• Updated: 1 March 2024

Report on all regulations in force during the first reporting period made using the powers in specific sections of the act, including stakeholder feedback and the department’s response.

• From: Department of Health and Social Care
• Updated: 29 February 2024

The Medicines and Healthcare Products Regulatory Agency (MHRA) have launched a public consultation to propose reclassification of Codeine Linctus to prescription-only medicine.

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 20 February 2024

This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.

• From: Department of Health and Social Care
• Updated: 24 January 2024

The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription.

• From: Department of Health (Northern Ireland) and 3 others
• Updated: 24 January 2024

This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 21 December 2023

An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.

• From: Department of Health and Social Care
• Updated: 14 December 2023

The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.

• From: Medicines and Healthcare products Regulatory Agency
• Updated: 11 December 2023

We are seeking views on the legislation that will enable the GMC to regulate anaesthesia associates (AAs) and physician associates (PAs) in the UK.

• From: Department of Health and Social Care and 1 others
• Updated: 11 December 2023

The full government response to the Lord O'Shaughnessy independent review of UK commercial clinical trials.

• From: Department of Health and Social Care
• Updated: 8 December 2023

DHSC is seeking views on proposals to modernise legislation governing the supervision of activities by a pharmacist in a pharmacy.

• From: Department of Health and Social Care
• Updated: 7 December 2023

This consultation considers the proposed review of the statutory scheme to control the cost of branded health service medicines.

• From: Department of Health and Social Care
• Updated: 4 December 2023

The outline terms agreed between DHSC and the Association of the British Pharmaceutical Industry (ABPI) for the voluntary scheme.

• From: Department of Health and Social Care
• Updated: 21 November 2023